Patrick J. van Gorp

3.2k citations

42 papers · 2.6k · h-index 27

Impact in

Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
Endocrinology, Diabetes and Metabolism top 2%
- Diet, Metabolism, and Disease

Papers in

Epidemiology 20
- Liver Disease Diagnosis and Treatment 18
Molecular Biology 18
- Peroxisome Proliferator-Activated Receptors 6
- Sphingolipid Metabolism and Signaling 4
- Inflammasome and immune disorders 4

Co-authors: Marten H. Hofker (27 shared papers)Ronit Shiri‐Sverdlov (30 shared papers)Marion J. Gijbels (25 shared papers)Kristiaan Wouters (8 shared papers)Veerle Bieghs (15 shared papers)Dieter Lütjohann (11 shared papers)Marc van Bilsen (5 shared papers)Bart Staels (4 shared papers)
Journals: PLoS ONE (7 papers)Atherosclerosis (5 papers)Scientific Reports (2 papers)Journal of Hepatology (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Patrick J. van Gorp

42 papers receiving 2.6k citations

Peers

Countries citing papers authored by Patrick J. van Gorp

Since Specialization

Citations

This map shows the geographic impact of Patrick J. van Gorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. van Gorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. van Gorp more than expected).

Fields of papers citing papers by Patrick J. van Gorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. van Gorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. van Gorp. The network helps show where Patrick J. van Gorp may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick J. van Gorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick J. van Gorp Line = papers co-authored together Patrick J. van Gorp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis† Hepatology ·Kristiaan Wouters, Patrick J. van Gorp, Veerle Bieghs, Marion J. Gijbels, Hans Duimel, Dieter Lütjohann, Anja Kerksiek, Roger van Kruchten, Nobuyo Maeda, Bart Staels, Marc van Bilsen, Ronit Shiri‐Sverdlov, Marten H. Hofker	2008	391
2	Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates Journal of Hepatology ·Ronit Shiri‐Sverdlov, Kristiaan Wouters, Patrick J. van Gorp, Marion J. Gijbels, Benoît Noël, Laurent Buffat, Bart Staels, Nobuyo Maeda, Marc van Bilsen, Marten H. Hofker	2005	209
3	Bone Marrow–Specific Deficiency of Nuclear Receptor Nur77 Enhances Atherosclerosis Circulation Research ·Anouk A.J. Hamers, Mariska Vos, Fadi Rassam, Goran Marinković, Kondababu Kurakula, Patrick J. van Gorp, Menno P.J. de Winther, Marion J. Gijbels, Vivian de Waard, Carlie J.M. de Vries	2011	143
4	Role of Scavenger Receptor A and CD36 in Diet-Induced Nonalcoholic Steatohepatitis in Hyperlipidemic Mice Gastroenterology ·Veerle Bieghs, Kristiaan Wouters, Patrick J. van Gorp, Marion J. Gijbels, Menno P.J. de Winther, Christoph J. Binder, Dieter Lütjohann, Maria Febbraio, Kathryn J. Moore, Marc van Bilsen, Marten H. Hofker, Ronit Shiri‐Sverdlov	2010	132
5	LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease PLoS ONE ·Veerle Bieghs, Patrick J. van Gorp, Kristiaan Wouters, Tim Hendrikx, Marion J. Gijbels, Marc van Bilsen, Jaap Bakker, Christoph J. Binder, Dieter Lütjohann, Bart Staels, Marten H. Hofker, Ronit Shiri‐Sverdlov	2012	126
6	Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. Journal of Clinical Investigation ·M.C.M. de Jong, Marion J. Gijbels, Vivian E.H. Dahlmans, Patrick J. van Gorp, Sjoerd Koopman, Maria Ponec, Marten H. Hofker, Louis M. Havekes	1998	123
7	Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice Clinical Chemistry and Laboratory Medicine (CCLM) ·Kristiaan Wouters, Ronit Shiri‐Sverdlov, Patrick J. van Gorp, Marc van Bilsen, Marten H. Hofker	2005	116
8	Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells PLoS ONE ·Veerle Bieghs, Fons Verheyen, Patrick J. van Gorp, Tim Hendrikx, Kristiaan Wouters, Dieter Lütjohann, Marion J. Gijbels, Maria Febbraio, Christoph J. Binder, Marten H. Hofker, Ronit Shiri‐Sverdlov	2012	101
9	In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. Journal of Clinical Investigation ·M.C.M. de Jong, Vivian E.H. Dahlmans, Patrick J. van Gorp, Ko Willems van Dijk, M. Breuer, Marten H. Hofker, Louis M. Havekes	1996	99
10	Intrahepatic cholesterol influences progression, inhibition and reversal of non‐alcoholic steatohepatitis in hyperlipidemic mice FEBS Letters ·Kristiaan Wouters, Marc van Bilsen, Patrick J. van Gorp, Veerle Bieghs, Dieter Lütjohann, Anja Kerksiek, Bart Staels, Marten H. Hofker, Ronit Shiri‐Sverdlov	2010	86
11	Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice Atherosclerosis ·Menno P.J. de Winther, Marion J. Gijbels, Ko Willems van Dijk, Patrick J. van Gorp, Hiroshi Suzuki, Tatsuhiko Kodama, Rune R. Frants, Louis M. Havekes, Marten H. Hofker	1999	82
12	Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice Hepatology ·Veerle Bieghs, Patrick J. van Gorp, Sofie M. A. Walenbergh, Marion J. Gijbels, Fons Verheyen, Wim A. Buurman, David E. Briles, Marten H. Hofker, Christoph J. Binder, Ronit Shiri‐Sverdlov	2012	81
13	The Cholesterol Derivative 27-Hydroxycholesterol Reduces Steatohepatitis in Mice Gastroenterology ·Veerle Bieghs, Tim Hendrikx, Patrick J. van Gorp, Fons Verheyen, Yasmin Dias Guichot, Sofie M. A. Walenbergh, Mike L. J. Jeurissen, Marion J. Gijbels, Sander S. Rensen, Aalt Bast, Jogchum Plat, Satish C. Kalhan, Ger H. Koek, Eran Leitersdorf, Marten H. Hofker, Dieter Lütjohann, Ronit Shiri‐Sverdlov	2012	76
14	Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet Free Radical Biology and Medicine ·Katrin Schröder, Carmine Vecchione, Oliver Jung, Judith G. Schreiber, Ronit Shiri‐Sverdlov, Patrick J. van Gorp, Rudi Busse, Ralf P. Brandes	2006	68
15	Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition Journal of Lipid Research ·Stijn A.I. Ghesquiere, Marion J. Gijbels, Marit W. Anthonsen, Patrick J. van Gorp, Ingeborg van der Made, Berit Johansen, Marten H. Hofker, Menno P.J. de Winther	2004	68
16	Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation Liver International ·Veerle Bieghs, Sofie M. A. Walenbergh, Tim Hendrikx, Patrick J. van Gorp, Fons Verheyen, Steven W.M. Olde Damink, Ad Masclee, Ger H. Koek, Marten H. Hofker, Christoph J. Binder, Ronit Shiri‐Sverdlov	2013	68
17	Reprogramming macrophages to an anti‐inflammatory phenotype by helminth antigens reduces murine atherosclerosis The FASEB Journal ·Ine M. J. Wolfs, J. Lauran Stöger, Pieter Goossens, Chantal C. H. Pöttgens, Marion J. Gijbels, Erwin Wijnands, Emiel P. C. van der Vorst, Patrick J. van Gorp, Linda Beckers, David Engel, Erik A.L. Biessen, Georg Kraal, Irma van Die, Marjo M. P. C. Donners, Menno P.J. de Winther	2013	65
18	Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr^−/− mice FEBS Journal ·Tim Hendrikx, Mike L. J. Jeurissen, Patrick J. van Gorp, Marion J. Gijbels, Sofie M. A. Walenbergh, Tom Houben, Rick van Gorp, Chantal C. H. Pöttgens, Rinke Stienstra, Mihai G. Netea, Marten H. Hofker, Marjo M. P. C. Donners, Ronit Shiri‐Sverdlov	2015	58
19	Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E3Leiden and Human Apolipoprotein C1 Arteriosclerosis Thrombosis and Vascular Biology* ·Miek C. Jong, Vivian E.H. Dahlmans, Patrick J. van Gorp, Marco L. Breuer, M.J.T.M. Mol, André van der Zee, Rune R. Frants, Marten H. Hofker, Louis M. Havekes	1996	52
20	Cathepsin D regulates lipid metabolism in murine steatohepatitis Scientific Reports ·Tom Houben, Yvonne Oligschlaeger, Tim Hendrikx, Albert V. Bitorina, Sofie M. A. Walenbergh, Patrick J. van Gorp, Marion J. Gijbels, Silvia Friedrichs, Jogchum Plat, Frank G. Schaap, Dieter Lütjohann, Marten H. Hofker, Ronit Shiri‐Sverdlov	2017	48

About Patrick J. van Gorp

Patrick J. van Gorp is a scholar working on Epidemiology, Molecular Biology, Surgery, Immunology and Cardiology and Cardiovascular Medicine, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Cholesterol and Lipid Metabolism (10 papers), Lipid metabolism and disorders (8 papers), Atherosclerosis and Cardiovascular Diseases (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Sphingolipid Metabolism and Signaling (4 papers), Inflammasome and immune disorders (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Epidemiology (1.2k citations), Endocrinology, Diabetes and Metabolism (550 citations), Hepatology (236 citations), Immunology (517 citations) and Biochemistry (127 citations). Patrick J. van Gorp has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Marten H. Hofker, Ronit Shiri‐Sverdlov, Marion J. Gijbels, Kristiaan Wouters, Veerle Bieghs, Dieter Lütjohann, Marc van Bilsen, Bart Staels, Tim Hendrikx and Louis M. Havekes. Their work appears in journals such as PLoS ONE, Atherosclerosis, Scientific Reports, Journal of Hepatology and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Patrick J. van Gorp

Impact in

Papers in i

In The Last Decade

Patrick J. van Gorp

Peers

Countries citing papers authored by Patrick J. van Gorp

Fields of papers citing papers by Patrick J. van Gorp

All Works

About Patrick J. van Gorp

Explore authors with similar magnitude of impact

Papers in